NANOG and cervical cancer: An IHC study clarified the expression of NANOG in patients with cervical cancer and cervical dysplasia, and its expression was found to be significantly higher in cervical cancer than in cervical dysplasia and higher in cervical dysplasia than in normal cervical epithelia [174], supporting the role of NANOG in carcinogenesis and cervical carcinoma progression.